The global COVID-19 pandemic has led to changes in public health measures causing significant disruption across lung cancer screening, diagnosis, treatment and management pathways. The pandemic has presented many challenges for lung cancer patients. These measures have also impacted people's behaviour and their interaction with the healthcare system. Therefore, increased knowledge of the broader as well as biological impacts of COVID-19 on lung cancer patients' health, is required.
To help address this need, BMC Pulmonary Medicine has published this collection to bring together research on:
- characterizing the interaction of COVID-19 and lung cancer,
- health-related behavior changes impacting lung cancer patients,
- the effect of changes to lung cancer care pathways,
- and the long term impact of the pandemic on lung cancer patients.
We also encouraged submissions discussing what we can learn from the pandemic to help build a better future for lung cancer research and care.